Does Scalp Cooling Have the Same Efficacy in Black Patients Receiving Chemotherapy for Breast Cancer?
CONCLUSION: SC may not be efficacious in preventing alopecia in Black women. Differences in hair thickness, hair volume, and limitations of cooling cap design are possible contributing factors.
RESULTS: 15 patients enrolled in the intervention before the study was closed early due to lack of efficacy. Median MDS and CADS increased after SC suggesting increased hair loss (p < .001) and alopecia distress (p = .04). Only one participant was successful in preventing significant hair loss; the majority stopped SC before chemotherapy completion due to grade 3 alopecia (>50% hair loss).
PMID: 33512741 [PubMed - as supplied by publisher]
Source: The Oncologist - Category: Cancer & Oncology Authors: Dilawari A, Gallagher C, Alintah P, Chitalia A, Tiwari S, Paxman R, Adams-Campbell L, Dash C Tags: Oncologist Source Type: research
More News: Alopecia | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Lessons | Study | Women